13 results
IDSA 2017 CDiff Guidelines - Table 1. Recommendations for the Treatment of Clostridium difficile Infection in Adults

#Management
IDSA 2017 CDiff ... Guidelines - Table 1. ... Recommendations for the Treatment ... Infection in Adults ... #Clostridium #CDifficile
Anti-C. Difficile - Antibiotics Class Overview
 1. Metronidazole – (see anti-anaerobe section above for more details).
Class Overview 1. ... infection (defined ... therapy for severe C.diff ... infection (WBC ... Review #Overview #CDifficile
IDSA 2017 CDiff Guidelines - Table 7. Potential Treatment Agents for Treatment of the Primary Clostridium difficile
IDSA 2017 CDiff ... Potential Treatment ... Agents for Treatment ... infection Episode ... #Clostridium #CDifficile
IDSA 2017 CDiff Guidelines - Table 2. Recommendations for the Treatment of Clostridium difficile Infection in Children

#Management
IDSA 2017 CDiff ... Recommendations for the Treatment ... of Clostridium difficile ... Infection in Children ... #Clostridium #CDifficile
Causes of Antibiotic Failure - Differential Diagnosis Framework
Diagnosis:
 • Non-Infectious: Malignant, Autoimmune, Drug-related (NMS, serotonin syndrome,
Diagnosis: • Non-Infectious ... take 48 hrs for infections ... rxn), Secondary infection ... (C diff) • Hospital-Acquired ... Infection: IV catheter
C.diff - Clostridioides Difficile Infection (CDI) - Diagnosis and Management - GrepMed Handbook

Clinical Presentation + Progression:
Difficile Infection ... nosocomial infection ... can be community-acquired ... ciab549 #CDI #Cdiff ... #Clostridium #Infection
Systemic Inflammatory Response Syndrome (SIRS)
•	Non-specific (infections vs non-infectious)
•	≥2 of the following:
o	Temp >38°C or <36°C
o	HR >90 bpm
o	RR
Non-specific (infections ... vs non-infectious ... host response to infection ... + circulatory failure ... (within 1 hour)
Potential Treatment Agents for Treatment of the Primary Clostridium difficile infection Episode
Proven efficacy:
 • Vancomycin -
Potential Treatment ... Primary Clostridium difficile ... infection Episode ... × 10 days #CDiff ... #pharmacology #idsa
IDSA Recommendations for Treating Mucosal Candidiasis in HIV-AIDS
Oropharyngeal Candidiasis: Initial Episodes (Duration of Therapy: 7–14 days)
Preferred
IDSA Recommendations ... 4–6 mL QID or 1– ... antifungals are required ... candida #mucosal #IDSA ... opportunistic #infections
Capnocytophaga
Pathogen: Capnocytophaga
 • 9 species, C. canimorsus responsible for the majority of infections
 • Gram-negative rod,
the majority of infections ... Incubation period is 1- ... malaise • Septic shock ... : CID, Renal failure ... Treatment: • 50%